SE411755B - Forfarande for framstellning av n-substituerade 1-aminometylindaner - Google Patents

Forfarande for framstellning av n-substituerade 1-aminometylindaner

Info

Publication number
SE411755B
SE411755B SE7209669A SE966972A SE411755B SE 411755 B SE411755 B SE 411755B SE 7209669 A SE7209669 A SE 7209669A SE 966972 A SE966972 A SE 966972A SE 411755 B SE411755 B SE 411755B
Authority
SE
Sweden
Prior art keywords
aminomethylindanes
substituted
procedure
preparation
Prior art date
Application number
SE7209669A
Other languages
English (en)
Swedish (sv)
Inventor
W Himmele
A Amann
W Aquila
H Giertz
H Siegel
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of SE411755B publication Critical patent/SE411755B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7209669A 1971-07-26 1972-07-24 Forfarande for framstellning av n-substituerade 1-aminometylindaner SE411755B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2137276A DE2137276A1 (de) 1971-07-26 1971-07-26 N-substituierte 1-aminomethylindane

Publications (1)

Publication Number Publication Date
SE411755B true SE411755B (sv) 1980-02-04

Family

ID=5814830

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7209669A SE411755B (sv) 1971-07-26 1972-07-24 Forfarande for framstellning av n-substituerade 1-aminometylindaner

Country Status (11)

Country Link
US (1) US3886168A (de)
JP (1) JPS5824433B1 (de)
AT (1) AT316534B (de)
BE (1) BE786748A (de)
CA (1) CA978184A (de)
CH (1) CH583169A5 (de)
DE (1) DE2137276A1 (de)
FR (1) FR2147209B1 (de)
GB (1) GB1394859A (de)
NL (1) NL7209802A (de)
SE (1) SE411755B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4005093A (en) * 1975-01-20 1977-01-25 Sterling Drug Inc. 2-Naphthyl-lower-alkylamines
US4130646A (en) * 1975-07-25 1978-12-19 E. R. Squibb & Sons, Inc. 1,2,3,4-Tetrahydro-2-((4-(phenyl)-1-piperazinyl)methyl)-1-naphthalenols and derivatives and analogs thereof
JPS52133993A (en) * 1976-04-29 1977-11-09 Takeda Chem Ind Ltd 1.2-dihydronaphthalene derivatives and method of preparing the same
DE2862103D1 (en) * 1977-08-19 1982-11-18 Sandoz Ag Propenyl amines, processes for their production and pharmaceutical compositions containing them
US5334628A (en) * 1984-06-09 1994-08-02 Kaken Pharmaceutical Co., Ltd. Amine derivatives, processes for preparing the same and fungicides containing the same
JPS6145A (ja) * 1984-06-09 1986-01-06 Kaken Pharmaceut Co Ltd Ｎ‐（４‐ｔｅｒｔ‐ブチルベンジル）‐Ｎ‐メチル‐１‐ナフチルメチルアミンおよびそれを有効成分とする抗真菌剤
GB8704572D0 (en) * 1987-02-26 1987-04-01 Lundbeck & Co As H Organic compounds
ES2059570T3 (es) * 1988-01-15 1994-11-16 Abbott Lab 1-aminometil-1,2,3,4-tetrahidronaftalenos e -indanos.
ES2055011T3 (es) * 1988-09-19 1994-08-16 Akzo Nv Un procedimiento para la preparacion de derivados de tetrahidronaftaleno e indano.
EP0738149B1 (de) * 1994-01-10 2006-11-29 Teva Pharmaceutical Industries, Ltd. 1-aminoindanderivate und zusammensetzungen hiervon
US5877218A (en) * 1994-01-10 1999-03-02 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
DE69732984T2 (de) 1996-12-18 2006-02-16 Teva Pharmaceutical Industries Ltd. Aminoindanderivate
US6737547B1 (en) 1998-12-31 2004-05-18 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using N-acyl-1H-aminoindenes
AU775885B2 (en) * 1999-10-27 2004-08-19 Teva Pharmaceutical Industries Ltd. Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder
US20040010038A1 (en) * 2002-02-27 2004-01-15 Eran Blaugrund Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors
US20070135518A1 (en) * 2005-12-09 2007-06-14 Marta Weinstock-Rosin Use of low-dose ladostigil for neuroprotection
BRPI0620659A2 (pt) * 2005-12-09 2017-10-31 Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd método para a prevenção do aparecimento de sintomas de uma doença neurodegenerativa em um indivíduo predisposto à doença neurodegenerativa, método de redução de stress oxidante no cérebro de um indivíduo afligido com stress oxidante, método de tratamento de um indivíduo afligido com a degeneração cognitiva suave e composição farmacêutica
TW200744576A (en) * 2006-02-24 2007-12-16 Teva Pharma Propargylated aminoindans, processes for preparation, and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3706756A (en) * 1969-02-03 1972-12-19 Ciba Geigy Corp Aminoalkyl-spirocycloalkanes
BE757408A (fr) * 1969-10-13 1971-04-13 Thomae Gmbh Dr K Nouveaux butanols tertiaires a constituants basiques
US3704323A (en) * 1969-12-23 1972-11-28 Squibb & Sons Inc Indane derivatives
US3725412A (en) * 1969-12-29 1973-04-03 Sandoz Ag Substituted {60 ,{60 ,{65 -triphenyl-aminopropanols

Also Published As

Publication number Publication date
US3886168A (en) 1975-05-27
DE2137276A1 (de) 1973-02-08
CH583169A5 (de) 1976-12-31
CA978184A (en) 1975-11-18
AT316534B (de) 1974-07-10
FR2147209B1 (de) 1975-10-17
GB1394859A (en) 1975-05-21
JPS5824433B1 (de) 1983-05-20
NL7209802A (de) 1973-01-30
FR2147209A1 (de) 1973-03-09
BE786748A (fr) 1973-01-26

Similar Documents

Publication Publication Date Title
SE392269B (sv) Forfarande for framstellning av vissa indanyloxitetrazoler
SE432102B (sv) Forfarande for framstellning av estrar av penicilliner
SE398877B (sv) Forfarande for framstellning av 14-hydroxi-morfinanderivat
SE411755B (sv) Forfarande for framstellning av n-substituerade 1-aminometylindaner
SE406197B (sv) Analogiforfarande for framstellning av 4-aminokinazolinderivat
SE400292B (sv) Forfarande for framstellning av benshydryl-3-karbamoyloximetyl-7-tienylacetamido-7-metoxidecefalosporanat
SE390633B (sv) Forfarande for framstellning av ethambutol
SE417200B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE400764B (sv) Forfarande for framstellning av substituerade 3-hydroximetylisokinoliner
SE393615B (sv) Forfarande for framstellning av 6-metyl-8 beta-ureidometyl-ergolener
SE405478B (sv) Forfarande for framstellning av alfa-sulfoacylcefalosporiner
SE397090B (sv) Forfarande for framstellning av hydroxipyrimidiner
SE384686B (sv) Forfarande for framstellning av linkomycinderivat
SE399069B (sv) Analogiforfarande for framstellning av triazolo-pyridino-isokinolin-derivat
SE412756B (sv) Alternativa forfarande for framstellning av 2-(aminofenylimino)-3-aza-1-tia-cykloalkaner
SE408177B (sv) Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat
SE387936B (sv) Forfarande for framstellning av substituerade metoxiaminer
SE382985B (sv) Forfarande for framstellning av oxazoler
SE380520B (sv) Forfarande for framstellning av 1-cinnamylidenamino-3-bensylidenaminoguanidin
SE394680B (sv) Forfarande for framstellning av cykliska fosfamidderivat
SE409866B (sv) Forfarande for framstellning av adenosinderivat
SE386897B (sv) Forfarande for framstellning av n-acyl-(piperazinoetyl)-pyrazoler
SE392902B (sv) Forfarande for framstellning av fenylimidazolidinoner
SE397350B (sv) Forfarande for framstellning av tieno-diazepinderivat
SE405730B (sv) Forfarande for framstellning av kinazolinderivat